CS0159
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for CS0159, covering 2023-11-21 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis) [Phase 2]